High-throughput biochemical assays targeting a vital viral protein identified one molecule out of more than 13,000 with promising antiviral activity against SARS-CoV-2.

Several PNNL scientists contributed to the virtual Society of Toxicology meeting in March.

Vigorous and rapid air exchanges might not always be a good thing when it comes to levels of coronavirus particles in a multiroom building, according to a new modeling study.

One year ago, Verizon announced a partnership that made PNNL the U.S. Department of Energy’s first national laboratory with Verizon 5G ultra-wideband wireless technology.

Sentry-SECURE is a new communication and response platform developed by PNNL, VPI, and Microsoft Azure that rapidly and securely transfers radiological alarm data through the cloud.

Tools being developed at PNNL are helping the nation plan for, respond to and recover from severe storms and wildfires that could threaten critical energy systems.

Night shift work disrupts the natural 24-hour rhythms in the activity of certain cancer-related genes, making workers more vulnerable to damage to their DNA.

PNNL designed a free, web-based tool to visually explore the National Response Framework.

As the COVID-19 pandemic continues, PNNL is offering support to its neighbors in the Mid-Columbia region and across Washington State.

Ann Lesperance, national security advisor, joins the National Academies of Sciences, Engineering, and Medicine Committee on Applied Research Topics for Hazard Mitigation and Resilience.

E-cigarette exposure stresses and inflames the lungs of rats, compromising important quality control proteins, according to new research.

In a first-of-its-kind study, PNNL scientists are learning about how e-cigarettes can lead to changes in proteins at the molecular level that could contribute to disease or other health problems.

A recent edition of the Infrastructure Resilience Research Group Journal featured an article written by PNNL researchers Rob Siefken and Jake Burns about “Design Basis Threat and the Low Threat Environment.”

Researchers at PNNL revisit a disaster recovery framework for relevance to COVID-19 pandemic.

Researchers at PNNL have developed a bacteria testing system called OmniScreen that combines biological and synthetic chemistry with machine learning to hunt down pathogens before they strike.

A zoonotic coronavirus known as SADS-CoV that has killed many pigs has the ability to infect human cells, surprising scientists.

A PNNL engineering team has designed personal protective equipment in support of COVID-19 aid.

Five PNNL technologies were recently awarded six R&D 100 honors. The R&D 100 Awards, now in its 58th year, recognize pioneers in science and technology from industry, the federal government, and academia.

The nation’s ability to test for COVID-19 has expanded, thanks to work at Pacific Northwest National Laboratory, where scientists have established the performance of testing equipment to detect the virus.

Researchers from PNNL have helped colleagues at OHSU identify lipid molecules required for Zika infection in human cells. The specific lipids involved could also be a clue to why the virus primarily infects brain tissue.